from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1773c/-

LFCtreatmentdescriptionclass of inhibitor

0.731

Amikacinug/mL Amikacintranslation

0.592

Cap5-10ug/mL Capreomycintranslation

-0.016

Rox10-50 ug/mL Roxithromycintranslation

0.398

SM2-5 ug/mL Streptomycintranslation

0.224

Tet5-10 ug/mL Tetracyclinetranslation

1.621

Rif0.2-5ug/mL Rifampicintranscription

0.163

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.036

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.878

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.465

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.986

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.163

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.720

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.296

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.651

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.156

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.787

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.587

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.340

KCN5-20 ug/mL Potassium cyaniderespiration

-0.770

NaN30.2-2 mM Sodium aziderespiration

-2.528

Nigericin50 uM Nigericinrespiration

0.344

TRC10-150 ug/mL Triclosanrespiration

0.678

TRZ10-25 ug/mL Thioridazinerespiration

-2.286

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.424

menadione6-10 ug/mL Menadionerespiration

-0.070

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.054

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.512

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.903

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.630

NRP_1Non-replicating persistence stage 1dosRassociated

0.380

Amp0.2mg/mL AmpicillincellWall

0.842

Cephalexin20-100 ug/mL CephalexincellWall

0.168

Cerulenin0.32-5 ug/mL CerulenincellWall

1.381

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.665

EMB10-20 ug/mL EthambutolcellWall

-0.122

Eta12-40 ug/mL EthionamidecellWall

-0.307

INH0.2-0.4 ug/mL IsoniazidcellWall

0.494

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.622

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.900

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.127

BZA0.12 mg/mL BenzamidearomaticAmides

0.033

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.557

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.065

H2O24 mM hydrogen peroxideDNAdamaging

0.094

Levo10 ug/mL LevofloxacinDNAdamaging

-0.175

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.467

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.871

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.295

UVUV-irradiationDNAdamaging

-0.206

ARP41-4 ug/mL Antitubercular compound ARP4?

0.040

Antimycin12.5-50 ug/mL Antimycin A?

-1.858

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.644

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.738

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.351

PA8240.2-2 ug/mL PA-824?

0.816

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.435

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.549

Verapamil50 uM Verapamil?

-1.778

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.202

methoxatin10-20 ug/mL Methoxatin?